BioCentury | Oct 28, 2019

Enleofen co-founders identify IL-11 as pulmonary fibrosis target

...DISEASE CATEGORY: Pulmonary INDICATION: Pulmonary fibrosis A National Heart Centre Singapore team led by Enleofen Bio Pte. Ltd. co-founders...
...al. Sci. Transl. Med. ; published online Sept. 25, 2019 doi:10.1126/scitranslmed.aaw1237 CONTACT: Stuart A. Cook, National Heart Centre Singapore...
BioCentury | Dec 5, 2017
Distillery Therapeutics

Cardiovascular; renal

...Schafer, S. et al. Nature ; published online Nov. 13, 2017 doi:10.1038/nature24676 CONTACT: Stuart Cook, National Heart Centre Singapore...
BioCentury | Nov 15, 2017
Preclinical News

Researchers identify IL-11 as new target for cardiovascular fibrosis

...such as liver, lung, skin and eye. Enleofen Bio Pte. Ltd. (Singapore), a spinout from National Heart Centre Singapore...
Items per page:
1 - 3 of 3
BioCentury | Oct 28, 2019

Enleofen co-founders identify IL-11 as pulmonary fibrosis target

...DISEASE CATEGORY: Pulmonary INDICATION: Pulmonary fibrosis A National Heart Centre Singapore team led by Enleofen Bio Pte. Ltd. co-founders...
...al. Sci. Transl. Med. ; published online Sept. 25, 2019 doi:10.1126/scitranslmed.aaw1237 CONTACT: Stuart A. Cook, National Heart Centre Singapore...
BioCentury | Dec 5, 2017
Distillery Therapeutics

Cardiovascular; renal

...Schafer, S. et al. Nature ; published online Nov. 13, 2017 doi:10.1038/nature24676 CONTACT: Stuart Cook, National Heart Centre Singapore...
BioCentury | Nov 15, 2017
Preclinical News

Researchers identify IL-11 as new target for cardiovascular fibrosis

...such as liver, lung, skin and eye. Enleofen Bio Pte. Ltd. (Singapore), a spinout from National Heart Centre Singapore...
Items per page:
1 - 3 of 3